Farallon Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-340,000
| Closed | -$40M | – | 102 |
|
|
2015
Q3 | $40M | Sell |
340,000
-420,000
| -55% | -$49.4M | 0.53% | 40 |
|
|
2015
Q2 | $58.8M | Sell |
760,000
-400,000
| -34% | -$31M | 0.79% | 36 |
|
|
2015
Q1 | $67.1M | Sell |
1,160,000
-225,000
| -16% | -$13M | 0.98% | 36 |
|
|
2014
Q4 | $44.7M | Buy |
1,385,000
+450,000
| +48% | +$14.5M | 0.61% | 39 |
|
|
2014
Q3 | $22.9M | Buy |
935,000
+501,186
| +116% | +$12.3M | 0.37% | 51 |
|
|
2014
Q2 | $7.69M | Sell |
433,814
-66,186
| -13% | -$1.17M | 0.11% | 68 |
|
|
2014
Q1 | $10M | Sell |
500,000
-62,352
| -11% | -$1.25M | 0.2% | 60 |
|
|
2013
Q4 | $9.44M | Buy |
562,352
+112,352
| +25% | +$1.89M | 0.2% | 57 |
|
|
2013
Q3 | $4.78M | Sell |
450,000
-187,500
| -29% | -$1.99M | 0.1% | 65 |
|
|
2013
Q2 | $3.56M | Buy |
+637,500
| New | +$3.56M | 0.07% | 68 |
|